Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by Yardsaleon Dec 04, 2018 5:01pm
74 Views
Post# 29064232

RE:cbdmd supply

RE:cbdmd supplyAnd did you see the numbers they're throwing around for anticipated revenue over the next 5 years? 


CHARLOTTE, N.C.--()--Level Brands, Inc. (NYSE American: LEVB) (the “Company”) announced today that it has signed a definitive merger agreement to acquire Cure Based Development, LLC the owner, operator and manufacturer of nationally recognized consumer cannabidiol (CBD) brand cbdMD, in a two-step merger for merger consideration of 15,525,000 shares of Level Brand’s common stock, with an earnout potential of up to an additional 15,525,000 shares if net revenue targets aggregating $300 million are met within 60 months of the closing date.

So let me get this straight... within 5 years just ONE of the complanies that Isodiol supplies isolate to could potentially sell 300 million in product?  
oh my...




budlight34 wrote: isodiol already supplies cbdmd..now we have another brand to sell containing isodiol cbd. sold thru level brands/kathy ireland for the next 10 years..ya this companies toast! NOT!!


Bullboard Posts